Sort by
Refine Your Search
-
Listed
-
Field
-
NASDAQ IPO. Having a comprehensive microfluidic toolbox at hand (and expanding it continuously), we are now inviting applications for highly multiplexed RNAseq-based screening for optimal T-cell expansion
-
imaging, high-content, single-cell resolution) to assay compound activity Develop imaging assays capable of distinguishing mechanism of action (e.g. growth inhibition, biofilm/attachment disruption
-
We welcome applicants with a PhD in neuroscience, cancer biology, cell biology, molecular biology, bioengineering, or a related field, together with excellent written and spoken English skills. We
-
, including physics, biophysics, cell biology, biochemistry, and engineering. We welcome applications from Postdoctoral candidates who are interested in developing their independent research ideas aligned with
-
neuroscience. Within this framework, AI models are co-developed with domain experts to unlock concrete biological questions and accelerate their translation to clinic. The large and interdisciplinary research